Robert Belknap

2.8k total citations
70 papers, 1.6k citations indexed

About

Robert Belknap is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Robert Belknap has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 37 papers in Epidemiology and 29 papers in Surgery. Recurrent topics in Robert Belknap's work include Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (21 papers) and Infectious Diseases and Tuberculosis (17 papers). Robert Belknap is often cited by papers focused on Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (21 papers) and Infectious Diseases and Tuberculosis (17 papers). Robert Belknap collaborates with scholars based in United States, Spain and United Kingdom. Robert Belknap's co-authors include Randall Reves, Richard Andrews, Michelle Haas, Gibril J. Njie, Timothy R. Sterling, David L. Cohn, Dick Menzies, C. Robert Horsburgh, Amina Ahmed and Carla A. Winston and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Robert Belknap

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Belknap United States 20 1.1k 884 633 98 98 70 1.6k
Mariana A. Hacker Brazil 24 991 0.9× 645 0.7× 243 0.4× 58 0.6× 12 0.1× 80 1.4k
A Wright United Kingdom 20 2.1k 1.9× 1.8k 2.0× 873 1.4× 308 3.1× 46 0.5× 43 2.8k
Amanda R. Smith United States 22 213 0.2× 437 0.5× 226 0.4× 133 1.4× 13 0.1× 56 1.8k
Ed Wilkins United Kingdom 22 671 0.6× 616 0.7× 431 0.7× 119 1.2× 21 0.2× 57 1.4k
Robert M. Cox United States 21 808 0.7× 660 0.7× 93 0.1× 236 2.4× 82 0.8× 57 1.6k
Jantjie Taljaard South Africa 19 460 0.4× 572 0.6× 122 0.2× 119 1.2× 10 0.1× 83 1.2k
Amy L. Davidow United States 24 855 0.8× 767 0.9× 352 0.6× 357 3.6× 42 0.4× 70 1.9k
Emma Aarons United Kingdom 22 891 0.8× 327 0.4× 47 0.1× 201 2.1× 33 0.3× 49 1.6k
Alexander Lee United States 23 191 0.2× 391 0.4× 301 0.5× 185 1.9× 28 0.3× 93 1.7k
Adauto Castelo Brazil 22 493 0.5× 577 0.7× 125 0.2× 152 1.6× 18 0.2× 70 1.5k

Countries citing papers authored by Robert Belknap

Since Specialization
Citations

This map shows the geographic impact of Robert Belknap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Belknap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Belknap more than expected).

Fields of papers citing papers by Robert Belknap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Belknap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Belknap. The network helps show where Robert Belknap may publish in the future.

Co-authorship network of co-authors of Robert Belknap

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Belknap. A scholar is included among the top collaborators of Robert Belknap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Belknap. Robert Belknap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beeson, Amy, Randall Reves, & Robert Belknap. (2024). Expanding evidence for shortened treatment of latent tuberculosis infection: progress, not perfection. Clinical Microbiology and Infection. 30(11). 1339–1340.
2.
Winters, Nicholas, Robert Belknap, Andrea Benedetti, et al.. (2023). Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. The Lancet Respiratory Medicine. 11(9). 782–790. 12 indexed citations
3.
Winglee, Kathryn, Christine Ho, April C. Pettit, et al.. (2023). Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States. Annals of the American Thoracic Society. 20(9). 1258–1266.
4.
Scott, Nigel, Andrew Vernon, Karlyn D. Beer, et al.. (2023). Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine. Contemporary Clinical Trials. 129. 107173–107173. 3 indexed citations
5.
Stout, Jason E., Nicholas Turner, Robert Belknap, et al.. (2019). Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling. American Journal of Respiratory and Critical Care Medicine. 201(5). 598–605. 2 indexed citations
6.
Haas, Michelle & Robert Belknap. (2019). Diagnostic Tests for Latent Tuberculosis Infection. Clinics in Chest Medicine. 40(4). 829–837. 49 indexed citations
7.
Belknap, Robert. (2018). Current Medical Management of Pulmonary Tuberculosis. Thoracic surgery clinics/Thorac. surg. clin.. 29(1). 27–35. 10 indexed citations
8.
Gaensbauer, James, et al.. (2018). Interferon-Gamma Release Assay-Based Screening for Pediatric Latent Tuberculosis Infection in an Urban Primary Care Network. The Journal of Pediatrics. 200. 202–209. 7 indexed citations
9.
Moro, Ruth N., Nigel Scott, Andrew Vernon, et al.. (2018). Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials. Annals of the American Thoracic Society. 15(5). 570–580. 42 indexed citations
10.
Stout, Jason E., et al.. (2018). Paradox of serial interferon-gamma release assays: variability width more important than specificity size. The International Journal of Tuberculosis and Lung Disease. 22(5). 518–523. 4 indexed citations
11.
Belknap, Robert, David P. Holland, Pei-Jean Feng, et al.. (2017). Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection. Annals of Internal Medicine. 167(10). 689–697. 103 indexed citations
12.
Belknap, Robert & Charles L. Daley. (2014). Interferon-Gamma Release Assays. Clinics in Laboratory Medicine. 34(2). 337–349. 14 indexed citations
13.
Dorman, Susan E., Robert Belknap, Edward A. Graviss, et al.. (2013). Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States. American Journal of Respiratory and Critical Care Medicine. 189(1). 77–87. 146 indexed citations
14.
Jenkins, Timothy C, et al.. (2012). Successful Limb-sparing Treatment Strategy for Diabetic Foot Osteomyelitis. Journal of the American Podiatric Medical Association. 102(4). 273–277. 15 indexed citations
15.
Beavers, Suzanne F., Jennifer Flood, Paul Weinfurter, et al.. (2012). Tuberculosis Mortality In The United States: How Can It Be Prevented?. A6062–A6062. 3 indexed citations
16.
Belknap, Robert, et al.. (2009). Eradication of multidrug-resistant Acinetobacter baumannii in a female patient with total hip arthroplasty, with debridement and retention: a case report. Journal of Medical Case Reports. 3(1). 45–45. 4 indexed citations
17.
Belknap, Robert. (2004). The List. Yale University Press eBooks. 27 indexed citations
18.
Andrews, Richard & Robert Belknap. (1993). Seasonal acclimation of prairie deer mice. International Journal of Biometeorology. 37(4). 190–193. 6 indexed citations
19.
Andrews, Richard & Robert Belknap. (1988). Differential effects of adrenergic blockade on seasonal changes in core temperatures and thermal conductances of deer mice maintained in thermal neutral environments. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 89(1). 113–116. 2 indexed citations
20.
Riseman, Edward M., Allen R. Hanson, & Robert Belknap. (1987). The Information Fusion Proble: Forming Token Aggregations Across. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariana A. Hacker Breakdown of academic impact, for papers by A Wright Breakdown of academic impact, for papers by Amanda R. Smith Breakdown of academic impact, for papers by Ed Wilkins Breakdown of academic impact, for papers by Robert M. Cox Breakdown of academic impact, for papers by Jantjie Taljaard Breakdown of academic impact, for papers by Amy L. Davidow Breakdown of academic impact, for papers by Emma Aarons Breakdown of academic impact, for papers by Alexander Lee Breakdown of academic impact, for papers by Adauto Castelo
Rankless by CCL
2026